Michael Marco, MD

@Doc_JinKim @USFHealth Hope all is ok. Stay safe Jin.

Nature is cruel. Lost my apartment to #Helene. #Milton on way to impact Tampa again. Fortunate to have friends & family who supported me during these disasters. Extremely thankful to @USFHealth that prioritized our safety. Everyone please give your loved ones a hug and stay safe!

The genomic landscape of 2,023 colorectal cancers | Nature. New insights into the genomic diversities of CRC using WGS. Interesting findings about different genomics in young onset CRC. #ColorectalCancer #YoungOnset #Genomics #CancerResearch nature.com/articles/s4158…

#DCRJournal visual abstract | Sacral Neuromodulation in Patients With Low Anterior Resection Syndrome: The SANLARS Randomized Clinical Trial: bit.ly/3umQkId @JohnRTMonsonMD @jendavidsmd @ScottRSteeleMD @Swexner @me4_so @ACPGBI @drtracyhull @ASCRS_1

TNT for anal adenocarcinoma and watch and wait. Read more in this month's #DCRJournal: bit.ly/4bVgSRI @JohnRTMonsonMD @jendavidsmd @ScottRSteeleMD @Swexner @me4_so @ACPGBI @drtracyhull @ASCRS_1

SPICY: Hot off the press at #ECCO2024 / first RCT of mesenteric excision for ileocolic #Crohn #IBDSurgery -> no effect on postop endoscopic recurrence from #AmsterdamMedicalCenter

Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial | Oncology | JAMA Network Open | JAMA Network jamanetwork.com/journals/jaman…

Congrats to all of the OPRA investigators and @DrGarciaAguilar - 5-year data presented today by Floris Verheij @MSKCancerCenter ; LCRT --> FOLFOX: higher rates of organ preservation, lower rates of local regrowth AND no decrement in oncologic outcomes @ASCO; #ASCO23 @ASCRS_1

@fsanchezvega @MSKCancerCenter @chatila_w @hswalch Great work!!

Our @MSKCancerCenter CRC team, including @chatila_w and @hswalch, will be presenting two abstracts today during the poster session between 9am-12:30pm at #AACR23. Please come and check them out if you are in Orlando (1/3).

@Farrukh2132 @AHPBA @Rutgers_NJMS @NJMSDeptSurgery Congrats !!

Now to the DMT with a distinguished panel #MSKcolorectalCME @MSKCancerCenter - low Rectal pMMR cancer - what to do? Treated via OPRA trial (pre-Janus)

We’re really, really excited to get this @ASCRS_1 Research Foundation funded study done! Just a little Hurricane to deal with first and off to the races. See you all ar #occ2022!

Mid/Lower #RectalCancer --> #Chemo First or #Radiation First: Does It Really Matter? Join me and other esteemed colleagues at the #MSKcolorectalCME on Nov. 11-12 @MSKCancerCenter where we'll delve into these complexities. Don't miss your chance to join us: bit.ly/3QxOby8

Another excellent talk by E Fokas on the rationale for and progress of ACO/ARO/AIO-18.1 - see that accrual folks!! - tells you the importance of having watch-and-wait integrated in the context of a modern Rectal cancer trial #Ficare2022 #OrganPreservation

@studniarek_adam @WeillCornell @MSKCancerCenter @NJMSDeptSurgery @DrGuarrera @DrGarciaAguilar @GGanttMD @DoctorHoRo Congrats and welcome to our family !

Excited and honored to match at @WeillCornell and @MSKCancerCenter for my colorectal surgery fellowship. Thank you to my family and all my mentors for the support @NJMSDeptSurgery @DrGuarrera @DrGarciaAguilar @DMichaelmarco @GGanttMD @DoctorHoRo

Join us (in-person/virtually) for the 6th Advances in #Colorectal Oncology Symposium this Nov. 11-12 @MSKCancerCenter This year's exciting program features world-renowned experts in the field of #colorectalcancer #rectalcancer #MSKcolorectalCME Register: bit.ly/3QxOby8

Wonderful presentation of @R_Perez_MD @TNS_2022 on near cCR. Take home message: immediate surgery if cCR is not achieved - delayed surgery results in worse survival.

Last speaker of the evening: the world renowned @DrGarciaAguilar. He discusses the response prediction to neoadjuvant therapy and clinical implications.

Very proud of our latest publication in Nature Medicine! One size doesn’t fit all in rectal cancer! Rectal Tumor biology affect the response to the neoadjuvant therapy #colorectalcancer

Very proud of our study published in @NEJM. 100% clinical complete response with dostarlimab alone in mismatch repair-deficient locally advanced #RectalCancer. No radiation or surgery! @ASCO #ASCO22 @MSKCancerCenter nejm.org/doi/full/10.10…

International rectal cancer forum is back!! Yes 2022!! Yes in person!! Mark your calendar now!! Hosted by the queen in coloproctology prof. Angelita Habr-Gama October 31st and November 1st. Don’t miss it!!